112 related articles for article (PubMed ID: 1316988)
1. Growth factor receptor regulation in the Minn-1 leprechaun: defects in both insulin receptor and epidermal growth factor receptor gene expression.
Goodman PA; Sbraccia P; Brunetti A; Wong KY; Carter JD; Rosenthal SM; Goldfine ID
Metabolism; 1992 May; 41(5):504-9. PubMed ID: 1316988
[TBL] [Abstract][Full Text] [Related]
2. Receptors for insulinlike growth factor I are defective in fibroblasts cultured from a patient with leprechaunism.
Van Obberghen-Schilling EE; Rechler MM; Romanus JA; Knight AB; Nissley SP; Humbel RE
J Clin Invest; 1981 Nov; 68(5):1356-65. PubMed ID: 6271812
[TBL] [Abstract][Full Text] [Related]
3. [A case of leprechaunism with disorders of insulin-like growth factor-I(IGF-I)/somatomedin C(SMC) binding protein and its receptor].
Funakoshi T; Morikawa H; Yamasaki A; Kobayashi A; Ueda Y; Mochizuki M; Matsuo M; Nakamura H; Matsuo T; Itoh H
Nihon Naibunpi Gakkai Zasshi; 1989 Feb; 65(2):99-112. PubMed ID: 2472974
[TBL] [Abstract][Full Text] [Related]
4. Fibroblasts from a leprechaun patient have defects in insulin binding and insulin receptor autophosphorylation.
Maassen JA; Klinkhamer MP; van der Zon GC; Sips H; Möller W; Krans HM; Lindhout D; Beemer FA
Diabetologia; 1988 Aug; 31(8):612-7. PubMed ID: 2851471
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts from a patient with leprechaunism are resistant to insulin, epidermal growth factor, and somatomedin C.
Kaplowitz PB; D'Ercole AJ
J Clin Endocrinol Metab; 1982 Oct; 55(4):741-8. PubMed ID: 6286709
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of insulin resistance in cultured fibroblasts from a patient with leprechaunism: impaired post-binding actions of insulin and multiplication-stimulating activity.
Craig JW; Larner J; Locker EF; Widom B; Elders MJ
Metabolism; 1984 Dec; 33(12):1084-96. PubMed ID: 6094962
[TBL] [Abstract][Full Text] [Related]
7. Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor.
Desbois-Mouthon C; Danan C; Amselem S; Blivet-Van Eggelpoel MJ; Sert-Langeron C; Goossens M; Besmond C; Capeau J; Caron M
Metabolism; 1996 Dec; 45(12):1493-500. PubMed ID: 8969282
[TBL] [Abstract][Full Text] [Related]
8. A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction.
Kadowaki T; Kadowaki H; Taylor SI
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):658-62. PubMed ID: 2300553
[TBL] [Abstract][Full Text] [Related]
9. Homozygous nonsense mutation in the insulin receptor gene of a patient with severe congenital insulin resistance: leprechaunism and the role of the insulin-like growth factor receptor.
Jospe N; Kaplowitz PB; Furlanetto RW
Clin Endocrinol (Oxf); 1996 Aug; 45(2):229-35. PubMed ID: 8881457
[TBL] [Abstract][Full Text] [Related]
10. Coupling of insulin-responsive glucose transport to receptors for insulin-like growth factor 1 in primary human fibroblasts.
Maassen JA; van der Zon GC
Eur J Biochem; 1990 Jul; 190(3):553-7. PubMed ID: 2164929
[TBL] [Abstract][Full Text] [Related]
11. Acromegaloid patients with type A insulin resistance: parallel defects in insulin and insulin-like growth factor-I receptors and biological responses in cultured fibroblasts.
Low L; Chernausek SD; Sperling MA
J Clin Endocrinol Metab; 1989 Aug; 69(2):329-37. PubMed ID: 2546962
[TBL] [Abstract][Full Text] [Related]
12. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor.
Zhang B; Roth RA
Biochemistry; 1991 May; 30(21):5113-7. PubMed ID: 1645190
[TBL] [Abstract][Full Text] [Related]
13. Defective receptors for platelet-derived growth factor AA in human fibroblasts with mutant insulin receptors.
Longo N
Biochem Biophys Res Commun; 1993 Dec; 197(2):812-7. PubMed ID: 8267620
[TBL] [Abstract][Full Text] [Related]
14. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.
Abuzzahab MJ; Schneider A; Goddard A; Grigorescu F; Lautier C; Keller E; Kiess W; Klammt J; Kratzsch J; Osgood D; Pfäffle R; Raile K; Seidel B; Smith RJ; Chernausek SD;
N Engl J Med; 2003 Dec; 349(23):2211-22. PubMed ID: 14657428
[TBL] [Abstract][Full Text] [Related]
15. Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance.
Longo N; Langley SD; Griffin LD; Elsas LJ
Am J Hum Genet; 1992 May; 50(5):998-1007. PubMed ID: 1315125
[TBL] [Abstract][Full Text] [Related]
16. [Donohue's syndrome (Leprechaunism)].
Imamura T; Kobayashi M
Nihon Rinsho; 1994 Oct; 52(10):2643-7. PubMed ID: 7983792
[TBL] [Abstract][Full Text] [Related]
17. Gene expression in human cells with mutant insulin receptors.
Melis R; Pruett PB; Wang Y; Longo N
Biochem Biophys Res Commun; 2003 Aug; 307(4):1013-20. PubMed ID: 12878213
[TBL] [Abstract][Full Text] [Related]
18. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
Kato M
Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor defects in leprechaunism. A multiple growth factor-resistant syndrome.
Reddy SS; Kahn CR
J Clin Invest; 1989 Nov; 84(5):1569-76. PubMed ID: 2808704
[TBL] [Abstract][Full Text] [Related]
20. Effects of dietary supplementation with cysteamine on growth hormone receptor and insulin-like growth factor system in finishing pigs.
Liu G; Wei Y; Wang Z; Wu D; Zhou A
J Agric Food Chem; 2008 Jul; 56(13):5422-7. PubMed ID: 18553891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
